Glider | $4,000,000 | (Apr 18, 2025)
Graze Social | $1,000,000 | (Apr 18, 2025)
Trellis Health | $1,800,000 | (Apr 18, 2025)
Certified by Founder
Lodge
Umoja Biopharma
start up
United States
- Seattle, Washington
- 21/01/2025
- Series C
- $100,000,000
Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patients have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies
- Industry Biotechnology Research
- Website https://www.umoja-biopharma.com/
- LinkedIn https://www.linkedin.com/company/umoja-biopharma/
Related People
Andy ScharenbergFounder
United States -
Seattle, Washington
Physician, Scientist, Entrepreneur, passionate about the impact that CAR T-cells can have on the treatment of cancer.
Exaforce Inc. | $75,000,000 | (Apr 18, 2025)
Pillar Security | $9,000,000 | (Apr 18, 2025)
Cy4Data Labs | $10,000,000 | (Apr 18, 2025)
Meadow | $14,000,000 | (Apr 18, 2025)
RISA | $3,500,000 | (Apr 18, 2025)
Vizzy | B Corp™ | $4,841,908 | (Apr 18, 2025)
Assort Health | $26,000,000 | (Apr 18, 2025)
Atomic(US1) | $3,000,000 | (Apr 17, 2025)
Skin Analytics | $19,833,225 | (Apr 17, 2025)